$7.61
0.45[6.28%]
At close: May 9
$7.61
0[0.00%]
After Hours: 6:57PM EDT
Altimmune
(NASDAQ:ALT)Altimmune Stock (NASDAQ:ALT), Quotes and News Summary
Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.
| Open | $7.220 |
| Close | $7.720 |
| Volume / Avg. | 4.552M / 4.570M |
| Day Range | 7.170 - 8.075 |
| 52 Wk Range | 2.090 - 14.840 |
| Market Cap | $539.513M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 49 |
| Short Interest | 28.96% |
| Days to Cover | 6.46 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Altimmune (ALT) stock?
You can purchase shares of Altimmune (NASDAQ: ALT) through any online brokerage.
Who are Altimmune's (ALT) competitors?
Other companies in Altimmune’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Altimmune (ALT) stock?
The latest price target for Altimmune (NASDAQ: ALT) was reported by Guggenheim on Monday, April 29, 2024. The analyst firm set a price target for 0.00 expecting ALT to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Altimmune (ALT)?
The stock price for Altimmune (NASDAQ: ALT) is $7.61 last updated Today at May 9, 2024 at 6:57 PM EDT.
Does Altimmune (ALT) pay a dividend?
There are no upcoming dividends for Altimmune.
When is Altimmune (NASDAQ:ALT) reporting earnings?
Altimmune’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Altimmune (ALT) going to split?
There is no upcoming split for Altimmune.
What sector and industry does Altimmune (ALT) operate in?
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.